Table 2.
Authors | Year | Eyes (N) | Follow-Up (Months) | ± 0.5 D (%) | ± 1 D (%) | SE at Last Visit (LogMAR) | Mean Change (LogMAR) |
---|---|---|---|---|---|---|---|
Igarashi et al81 | 2022 | 73 | 26 | 78 | 93 | −0.61 ± 0.71 | −0.20 ± 0.43 |
Papa-Vettorazzi et al52 | 2022 | 45 | 120 | 42 | 64 | −1.24 ± 1.51 | −0.75 ± 1.20 |
Packer69* | 2022 | 119 | 96 | 72 | 95.5 | −0.63 | N/A |
Zhao et al19 | 2022 | 32 | 6 | 100 | 100 | −0.04 | N/A |
Chen et al53 | 2022 | 116 | 12 | N/A | N/A | −0.48 ± 0.77 | −0.15 ± 0.37 |
Kamiya et al36 | 2022 | 172 | 12 | 91 | 100 | −0.14 ± 0.28 | −0.07 ± 0.26 |
Packer32 | 2022 | 629 | 6 | N/A | N/A | −0.08 ± 0.34 | N/A |
Chen et al72 | 2022 | 78 | 60 | N/A | N/A | −1.65 ± 1.30 | −0.94 ± 0.70 |
Pinto et al37 | 2021 | 106 | 12 | 86.8 | 94.3 | −0.16 ± 0.47 | −0.07 ± 0.25 |
232 | 12 | 85.8 | 97.4 | −0.10 ± 0.44 | −0.07 ± 0.35 | ||
Zhao et al45 | 2022 | 63 | 12 | 100 | N/A | −0.07 ± 0.22 | N/A |
55 | 12 | 96 | N/A | −0.11 ± 0.24 | N/A | ||
Cano-Ortiz et al44 | 2021 | 126 | 6 | 98 | 100 | N/A | N/A |
Kamiya et al51 | 2021 | 177 | 96 | 83 | 93 | −0.28 ± 0.36 | −0.13 ± 0.30 |
Fernández-Vega-Cueto et al41 | 2021 | 84 | 84 | 53.57 | 80.95 | −0.62 ± 0.62 | N/A |
Chen et al50 | 2021 | 43 | 60 | 60.47 | 79.07 | −0.67 ± 0.57 | −0.72 ± 0.54 |
40 | 60 | 22.5 | 47.5 | −1.74 ± 1.19 | −1.05 ± 0.61 | ||
Reinstein et al101 | 2021 | 42 | 12 | 74 | 98 | −0.19 ± 0.36 | −0.12 |
Wei et al42 | 2021 | 42 | 6 | 93 | 100 | N/A | N/A |
46 | 6 | 91 | 100 | N/A | N/A | ||
Aruma et al48 | 2021 | 32 | 12 | 87 | 100 | −0.38 ± 0.20 | N/A |
Ye et al95 | 2021 | 104 | 42 | 61 | 91 | −0.99 ± 0.77 | N/A |
Martínez-Plaza et al91 | 2021 | 36 | 6 | 86.11 | 100 | +0.11 ± 0.40 | N/A |
Jiang et al14 | 2021 | 48 | 12 | 97.92 | 100 | N/A | −0.12 ± 0.37 |
Yang et al96 | 2021 | 42 | 51 | 79 | 100 | −0.20 ± 0.32 | N/A |
Yang et al73 | 2021 | 48 | 52 | 79 | 100 | −0.20 ± 0.32 | N/A |
Zhao et al97 | 2021 | 65 | 52 | 86 | 100 | −0.37 ± 0.31 | N/A |
Yu et al84 | 2020 | 38 | 3 | N/A | 97.4 | N/A | 0.08 ± 0.6 |
Wei et al56 | 2020 | 94 | 6 | 95 | 100 | −0.09 ± 0.25 | N/A |
Chen et al75 | 2020 | 26 | 12 | N/A | N/A | −0.36 ± 0.98 | N/A |
Kato et al58 | 2020 | 16 | 12 | 96 | 100 | N/A | −0.13 ± 0.26 |
Niu et al47 | 2020 | 39 | 12 | 90 | 100 | 0.07 ± 0.23 | N/A |
Wan et al98 | 2020 | 27 | 6 | 96 | 100 | N/A | −0.01 ± 0.24 |
29 | 6 | 100 | 100 | N/A | −0.03 ± 0.24 | ||
54 | 6 | 100 | 100 | N/A | −0.03 ± 0.33 | ||
27 | 6 | 81 | 96 | N/A | −0.00 ± 0.44 | ||
Tañ ´ a-Rivero et al99 | 2020 | 33 | 12 | 87.8 | 93.9 | −0.09 ± 0.47 | N/A |
Siedlecki et al18 | 2020 | 40 | 26 | 90 | 100 | −0.17 ± 0.33 | N/A |
Chaitanya et al100 | 2020 | 109 | 6 | 96.3 | 100 | N/A | N/A |
Zhao et al76 | 2019 | 37 | 18 | 66.7 | 100 | −0.48 ± 0.23 | N/A |
Alfonso et al40 | 2019 | 147 | 60 | 67.4 | 90.1 | −0.44 ± 0.47 | N/A |
Sachdev et al102 | 2019 | 203 | 12 | 94.09 | 96.06 | N/A | N/A |
Kamiya et al38 | 2018 | 57 | 12 | 93 | 98 | N/A | −0.12 ± 0.34 |
294 | 12 | 94 | 99 | N/A | −0.18 ± 0.43 | ||
Miao et al86 | 2018 | 67 | 3 | 72 | 95 | N/A | N/A |
Total of eyes reported | 4032 | 3145 | 3065 | 2849 | 1714 | ||
Weighted average | 25.2 | 84.2 | 95.4 | −0.33 | −0.20 |
Note: *Data at the 8th year are used.
Abbreviations: LogMAR, Logarithm of the Minimum Angle of Resolution; N/A, not available; SE, spherical equivalent; UDVA, uncorrected distance visual acuity.